In the last 48 hours:
– BioNTech announced human trials for cancer vaccines using mRNA technology
– Moderna announced promising data on a 3-in-1 respiratory vaccine—a FluRona shot that also protects against RSV
LFG 🚀 🚀 🚀 https://t.co/DZKXmTz1Xh
— Derek Thompson (@DKThomp) September 10, 2021
Noice.